Research and Development

Showing 15 posts of 9603 posts found.

_97604447_kymriah-product-shot-8

CAR-T is bringing true precision to the fight against cancer

November 1, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Gilead, Kymriah, Novartis, Yescarta

Matt Fellows investigates how the first-ever CAR-T therapy approvals in the past months could mean the field of cancer treatment …
roche

Roche’s Tecentriq approved for funding in UK in bladder cancer

November 1, 2017 Research and Development, Sales and Marketing Roche, biotech, drugs, pharma, pharmaceutical

In a rare spot of good news for Tecentriq (atezolizumab), after a turbulent period, Roche’s drug has been given the …

Indivior’s opioid addiction treatment recommended by FDA advisory panel

November 1, 2017 Research and Development, Sales and Marketing FDA, RGP-6000, Trump, US, indivior, opioid crisis, opioids

Another step has been made in the fight back against the ongoing opioid crisis in the US as it emerges …

CEO and President implicated as price-fixing probe widens

November 1, 2017 Research and Development, Sales and Marketing Mylan, Teva, biotech, drugs, pharma, pharmaceutical

A group of states, 45 members-strong, has expanded its probe into the generics pharmaceutical industry by expanding its case to …
astrazeneca-sign

AstraZeneca asthma therapy tralokinumab flops at Phase 3

November 1, 2017 Research and Development AstraZeneca, MedImmune, asthma, pharma

AstraZeneca and MedImmune, the company’s global biologics research and development arm, have announced new Phase 3 data revealing that tralokinumab …
nhs_sign

Cancer death rates 61% higher in poorer areas

November 1, 2017 Medical Communications, Research and Development NHS, biotech, drugs, pharma, pharmaceutical

Figures released by NHS Scotland have revealed that the numbers of deaths from cancer are 67% higher in the poorest …
alzheimers_brain

Over-the-counter multinutrient drink could have beneficial impact on Alzheimer’s, new study reveals

October 31, 2017 Manufacturing and Production, Research and Development Alzheimer's, Fortasyn Connect, Souvenaid, dementia

LipiDiDiet, a European project investigating “the impact of nutritional lipids on neuronal and cognitive performance in ageing, Alzheimer’s disease and …
amgen_hq

Kirin Holdings to withdraw from 30 year venture with Amgen, sell shares for $780m

October 31, 2017 Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Kirin, joint venture, pharma

Japanese firm Kirin Holdings has announced its intention to withdraw from a joint research collaboration with Amgen, saying it would …
janssen_latest_logo_on_sign_closer

Janssen’s Stelara shows improvement in Crohn’s symptoms within one week, new findings reveal

October 30, 2017 Manufacturing and Production, Research and Development Crohn’s disease, Janssen, Stelara, crohn's disease, pharma

Janssen has unveiled new data on Stelara (ustekinumab) in the treatment of patients with moderately to severely active Crohn’s disease …
pfizer-building-logo1web

Switching Crohn’s patients to biosimilar Inflectra from Remicade is safe and effective, Pfizer says

October 30, 2017 Research and Development, Sales and Marketing Crohn’s disease, Pfizer, Remicade, crohn's disease, inflectra, pharma

Pfizer has released new data on its Crohn’s disease (CD) treatment Inflectra (infliximab CT-P13) which indicate that switching patients to …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

October 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

October is almost over and Halloween is just around the corner, and it’s time for another run-down of the stories …
abbvieuse_054_low

AbbVie’s psoriasis drug smashes all endpoints

October 26, 2017 Medical Communications, Research and Development AbbVie, IL-23, biotech, drugs, pharma, pharmaceutical, risankizumab

AbbVie already know well what it’s like to have a lead candidate in the psoriasis field, after having Humira sat …
amber_hr_2

Is the NHS prepared for the upcoming winter season?

October 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insider Interview, Interview, NHS, pharma

After the health service struggled through the same period last year, Amber Jabbal, Head of Policy at NHS Providers sets …

Mental health problems cause 300,000 to leave work each year

October 26, 2017 Research and Development biotech, drugs, mental health, pharma, pharmaceutical

A report commissioned by Prime Minister, Theresa May, has found that 300,000 people are leaving their positions of work after …
The Gateway to Local Adoption Series

Latest content